The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype.
Antisense transcript
Gene expression
Long non-coding RNA
Prostate cancer
Tumour growth
lncRNA
Journal
PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425
Informations de publication
Date de publication:
2021
2021
Historique:
received:
05
07
2019
accepted:
09
10
2020
entrez:
15
2
2021
pubmed:
16
2
2021
medline:
16
2
2021
Statut:
epublish
Résumé
It is now appreciated that long non-coding RNAs (lncRNAs) are important players in orchestrating cancer progression. In this study we characterized
Identifiants
pubmed: 33585078
doi: 10.7717/peerj.10280
pii: 10280
pmc: PMC7860111
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e10280Informations de copyright
©2021 Thomas et al.
Déclaration de conflit d'intérêts
The authors declare there are no competing interests.
Références
Oncogene. 2015 Apr 2;34(14):1745-57
pubmed: 24837363
Prostate Cancer Prostatic Dis. 2016 Mar;19(1):14-20
pubmed: 26503110
Genome Res. 2012 Sep;22(9):1775-89
pubmed: 22955988
Nature. 2011 Apr 7;472(7341):120-4
pubmed: 21423168
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Horm Cancer. 2015 Jun;6(2-3):120-7
pubmed: 25792547
Nat Med. 2015 Nov;21(11):1253-61
pubmed: 26540387
Mol Cell Biochem. 2007 Dec;306(1-2):255-60
pubmed: 17694278
Mol Cell Biol. 2016 May 02;36(10):1509-25
pubmed: 26976638
Cell Rep. 2013 Jun 27;3(6):2127-41
pubmed: 23727239
RNA Biol. 2015;12(6):628-42
pubmed: 25864709
Cell Rep. 2014 Oct 23;9(2):741-51
pubmed: 25373909
BJU Int. 2015 Jul;116(1):17-29
pubmed: 25046451
Nat Rev Mol Cell Biol. 2013 Nov;14(11):699-712
pubmed: 24105322
Cancer Lett. 2016 Dec 1;383(1):125-134
pubmed: 27693462
Ther Adv Med Oncol. 2017 May;9(5):307-318
pubmed: 28529548
Nat Struct Mol Biol. 2015 Jan;22(1):5-7
pubmed: 25565026
Genes Dev. 2011 Sep 15;25(18):1915-27
pubmed: 21890647
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
Genome Res. 2013 Mar;23(3):486-96
pubmed: 23212948
Cancer Res. 2012 Jan 1;72(1):122-32
pubmed: 22052462
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
JAMA Oncol. 2015 Jul;1(4):505-27
pubmed: 26181261
Cancer Res. 1994 May 15;54(10):2577-81
pubmed: 8168083
Transl Cancer Res. 2017 Feb;6(Suppl 1):S47-S50
pubmed: 28529909
In Vivo. 2001 Mar-Apr;15(2):157-62
pubmed: 11317521
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Prostate. 2005 Sep 15;65(1):35-43
pubmed: 15800936
G3 (Bethesda). 2017 Jun 7;7(6):1731-1741
pubmed: 28413162
Med Oncol. 2015 Jan;32(1):426
pubmed: 25502083
Am J Pathol. 2011 Jul;179(1):400-10
pubmed: 21703419
Oncol Lett. 2014 Oct;8(4):1788-1792
pubmed: 25202411
Cancer Cell. 2010 Jul 13;18(1):11-22
pubmed: 20579941
Oncotarget. 2016 Apr 5;7(14):17631-40
pubmed: 26872373
Nature. 2014 Jan 30;505(7485):635-40
pubmed: 24463510
Nat Genet. 2016 Jan;48(1):12-21
pubmed: 26618344
Asian J Androl. 2014 May-Jun;16(3):407-12
pubmed: 24589467
Neoplasia. 2007 Feb;9(2):166-80
pubmed: 17356713
Nat Biotechnol. 2017 Apr 11;35(4):314-316
pubmed: 28398314
J Immunol. 2005 May 15;174(10):6477-89
pubmed: 15879151
Proc Natl Acad Sci U S A. 2016 May 31;113(22):6259-64
pubmed: 27185910
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
PLoS Genet. 2012;8(7):e1002841
pubmed: 22844254
EMBO Mol Med. 2015 Apr 20;7(7):878-94
pubmed: 25896606
Elife. 2014 Sep 16;3:e03523
pubmed: 25233276
Prostate. 2013 Feb 15;73(3):306-15
pubmed: 22911164
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):807-12
pubmed: 16467092
Mol Cancer Res. 2013 Jun;11(6):568-78
pubmed: 23493267
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1412-7
pubmed: 16432200
Mol Endocrinol. 2011 Apr;25(4):621-34
pubmed: 21330406
BMC Cancer. 2005 May 13;5:45
pubmed: 15892885
Biochem Cell Biol. 2017 Oct;95(5):578-584
pubmed: 28525724
Oncogene. 2014 Oct 23;33(43):5053-64
pubmed: 24276248
Biomed Pharmacother. 2016 Jul;81:25-30
pubmed: 27261573
Genome Biol. 2010;11(3):R25
pubmed: 20196867
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94
pubmed: 29115304
Transl Androl Urol. 2015 Jun;4(3):365-80
pubmed: 26814148
Nature. 2012 Jul 12;487(7406):239-43
pubmed: 22722839
Bioinformatics. 2007 Oct 15;23(20):2651-9
pubmed: 17720984
Tumour Biol. 2015 Aug;36(8):5753-5
pubmed: 26234767
Bioinformatics. 2007 Jul 15;23(14):1846-7
pubmed: 17496320
Mol Cancer. 2009 Aug 11;8:61
pubmed: 19671150
Oncotarget. 2017 Jun 27;8(26):43035-43047
pubmed: 28496006
Cell Rep. 2018 Apr 3;23(1):297-312.e12
pubmed: 29617668
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Cell. 2015 Nov 5;163(4):1011-25
pubmed: 26544944
Brief Bioinform. 2019 Sep 27;20(5):1853-1864
pubmed: 30010717
PLoS One. 2014 Jan 28;9(1):e84611
pubmed: 24489651
J Natl Cancer Inst. 2005 Sep 7;97(17):1287-96
pubmed: 16145049
Nat Genet. 2013 Nov;45(11):1392-8
pubmed: 24076601
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Nucleic Acids Res. 2015 Jan;43(Database issue):D812-7
pubmed: 25392408
Mol Ther. 2017 May 3;25(5):1069-1075
pubmed: 28366767
FEBS Lett. 2013 Dec 11;587(24):3892-7
pubmed: 24126060
Nucleic Acids Res. 2017 Jan 4;45(D1):D362-D368
pubmed: 27924014
Int J Oncol. 2019 Dec;55(6):1223-1236
pubmed: 31638176
Cancer Cell. 2017 Oct 9;32(4):474-489.e6
pubmed: 29017058
Sci Rep. 2017 Jan 19;7:40729
pubmed: 28102292
Br J Cancer. 2004 Feb 9;90(3):720-7
pubmed: 14760390
Oncotarget. 2017 Apr 25;8(17):29395-29405
pubmed: 27741511
Asian J Androl. 2016 Jul-Aug;18(4):543-8
pubmed: 27080479
Science. 2017 Jan 6;355(6320):
pubmed: 27980086
Mol Ther. 2019 Oct 2;27(10):1718-1725
pubmed: 31526596
Science. 2009 May 8;324(5928):787-90
pubmed: 19359544
Int J Oncol. 2013 Aug;43(2):566-74
pubmed: 23722988
Prostate. 2017 May;77(6):654-671
pubmed: 28156002
Biomed Pharmacother. 2016 Feb;77:92-7
pubmed: 26796271